Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation

Peripheral blood sample was donated by a 61 years old female patient diagnosed with acute myeloid leukemia secondary to a primary myelofibrosis harboring the 52-bp deletion in the CALR gene (c.1092_1143del, p.L367fs*46) and the R693X mutation in the ASXL1 gene (c.2077C>T, p.R693X). CD34+ cells we...

Full description

Saved in:
Bibliographic Details
Published in:Stem cell research 2017-10, Vol.24 (C), p.16-20
Main Authors: Gomez Limia, Cintia E., Devalle, Sylvie, Reis, Marcelo, Sochacki, Jaroslaw, Carneiro, Mayra, Madeiro da Costa, Rodrigo, D'Andrea, Mariana, Padilha, Telma, Zalcberg, Ilana R., Solza, Cristiana, Daumas, Adelmo, Rehen, Stevens, Monte-Mór, Bárbara, Bonamino, Martín H.
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Peripheral blood sample was donated by a 61 years old female patient diagnosed with acute myeloid leukemia secondary to a primary myelofibrosis harboring the 52-bp deletion in the CALR gene (c.1092_1143del, p.L367fs*46) and the R693X mutation in the ASXL1 gene (c.2077C>T, p.R693X). CD34+ cells were isolated from the sample and subjected to the reprogramming procedure by using the Sendai virus carrying the reprogramming factors Oct3/4, Sox2, Klf4 and c-Myc. iPS colonies generated retained the original mutations and displayed all the features of bona fide iPS cells.
ISSN:1873-5061
1876-7753
DOI:10.1016/j.scr.2017.08.006